Prognostic implications of hMLH1 and p53 immunohistochemical status in right-sided colon cancer

Diseases of the Colon and Rectum

Volumn 47, Issue 12, 2004, Pages 2086-2092

  Smyth, Edward F ^a   Sharma, Abhiram ^a   Sivarajasingham, Nala ^a   Hartley, John ^a   Monson, John R T ^a,b   Cawkwell, Lynn ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b CASTLE HILL HOSPITAL   (United Kingdom)

Author keywords

Colonic cancer; Immunohistochemistry; Mismatch repair; p53 mutation; Survival

Indexed keywords

PROTEIN MLH1; PROTEIN P53;

ADULT; AGED; ARTICLE; BLOOD VESSEL; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; FISHER EXACT TEST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MISMATCH REPAIR; MULTIVARIATE ANALYSIS; PHENOTYPE; PROGNOSIS; PROTEIN EXPRESSION;

EID: 13144256735     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-004-0710-0     Document Type: Article

References (22)

1. Cancer Research UK. Bowel cancer factsheet. May 2002.
2. Hilska M, Gronroos J, Collan Y, Laato M. Surgically treated adenocarcinomas of the right side of the colon during a ten year period: a retrospective study. Ann Chir Gynaecol 2001;90:45-9.
3. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
4. Fearon ER, Jones PA. Progressing toward a molecular description of colorectal cancer development. FASEB J 1992;6:2783-90.
5. Thibodeau SN, French AJ, Cunningham JM, et al. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 1998;58:1713-8.
6. Jass JR, Biden KG, Cummings MC, et al. Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J Clin Pathol 1999;52:455-60.
7. Cawkwell L, Gray S, Murgatroyd H, et al. Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair. Gut 1999;45:409-15.
8. Lindor NM, Burgart LJ, Leontovich O, et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002;20: 1043-8.
9. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260: 816-9.
10. Gryfe R, Kim H, Hsieh ET, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000;342:69-77.
11. Samowitz WS, Curtin K, Ma KN, et al. Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev 2001;10:917-23.
12. Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003;349:247-57.
13. Kaserer K, Schmaus J, Bethge U, et al. Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer. J Pathol 2000;190: 450-6.
14. Allegra CJ, Paik S, Colangelo LH, et al. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study. J Clin Oncol 2003;21:241-50.
15. Soong R, Grieu F, Robbins P, et al. p53 alterations are associated with improved prognosis in distal colonic carcinomas. Clin Cancer Res 1997;3:1405-11.
16. Soong R, Powell B, Elsaleh H, et al. Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumor site, stage, adjuvant chemotherapy and type of mutation. Eur J Cancer 2000;36: 2053-60.
17. Samowitz WS, Curtin K, Ma KN, et al. Prognostic significance of p53 mutations in colon cancer at the population level. Int J Cancer 2002;99:597-602.
18. Manne U, Weiss H, Myers R, et al. Nuclear accumulation of p53 in colorectal adenocarcinoma. Cancer 1998;83: 2456-67.
19. Phillips RK, Hittinger R, Blesovsky L, Fry JS, Fielding LP. Large bowel cancer: surgical pathology and its relationship to survival. Br J Surg 1984;71:604-10.
20. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
21. Cox D. Regression models and life-tables. J R Stat Soc [B] 1972;34:187-202.
22. Jass JR. Towards a molecular classification of colorectal cancer. Int J Colorectal Dis 1999;14:194-200.